MONECO Advisors LLC increased its stake in The Clorox Company (NYSE:CLX – Free Report) by 22.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,955 shares of the company’s stock after purchasing an additional 361 shares during the quarter. MONECO Advisors LLC’s holdings in Clorox were worth $318,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of CLX. State Street Corp grew its position in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares during the period. Mizuho Securities USA LLC grew its holdings in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the period. Geode Capital Management LLC increased its position in Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after buying an additional 33,970 shares in the last quarter. Stifel Financial Corp raised its stake in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after buying an additional 37,967 shares during the period. Finally, Van ECK Associates Corp lifted its position in shares of Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
Clorox Stock Down 1.7 %
Shares of CLX opened at $154.52 on Tuesday. The business’s 50 day simple moving average is $157.53 and its 200-day simple moving average is $160.03. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a market capitalization of $19.03 billion, a price-to-earnings ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.
Wall Street Analyst Weigh In
Several research firms recently issued reports on CLX. DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Evercore ISI lifted their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Finally, Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $158.21.
Read Our Latest Stock Analysis on CLX
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- P/E Ratio Calculation: How to Assess Stocks
- Finding Hidden Gems: Unconventional Penny Stock Investing
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Price Targets on NVIDIA Rise in Front of Earnings
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.